282 related articles for article (PubMed ID: 22157436)
1. Botulinum toxin a treatment in children with cerebral palsy: its effects on walking and energy expenditure.
Balaban B; Tok F; Tan AK; Matthews DJ
Am J Phys Med Rehabil; 2012 Jan; 91(1):53-64. PubMed ID: 22157436
[TBL] [Abstract][Full Text] [Related]
2. [Effects of botulinum toxin guided by electric stimulation on spasticity in ankle plantar flexor of children with cerebral palsy: a randomized trial].
Xu KS; Yan TB; Mai JN
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):913-7. PubMed ID: 17254459
[TBL] [Abstract][Full Text] [Related]
3. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial.
Koman LA; Brashear A; Rosenfeld S; Chambers H; Russman B; Rang M; Root L; Ferrari E; Garcia de Yebenes Prous J; Smith BP; Turkel C; Walcott JM; Molloy PT
Pediatrics; 2001 Nov; 108(5):1062-71. PubMed ID: 11694682
[TBL] [Abstract][Full Text] [Related]
5. Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy.
Kawano A; Yanagizono T; Kadouchi I; Umezaki T; Chosa E
J Orthop Sci; 2018 Mar; 23(2):389-393. PubMed ID: 29146092
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment.
Bottos M; Benedetti MG; Salucci P; Gasparroni V; Giannini S
Dev Med Child Neurol; 2003 Nov; 45(11):758-62. PubMed ID: 14580131
[TBL] [Abstract][Full Text] [Related]
7. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
Mousny M; Allington N
Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
[TBL] [Abstract][Full Text] [Related]
8. Effect of multisite botulinum toxin injections on gait quality in adults with cerebral palsy.
Marchiori C; Roche N; Vuillerme N; Zory R; Pradon D
Disabil Rehabil; 2014; 36(23):1971-4. PubMed ID: 24499209
[TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
10. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
[TBL] [Abstract][Full Text] [Related]
11. Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study.
Franzén M; Hägglund G; Alriksson-Schmidt A
BMC Musculoskelet Disord; 2017 Dec; 18(1):520. PubMed ID: 29228927
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based approach of the use of Botulinum toxin type A (BTX) in cerebral palsy.
Wong V
Pediatr Rehabil; 2003; 6(2):85-96. PubMed ID: 14534045
[TBL] [Abstract][Full Text] [Related]
13. Effects of botulinum toxin A therapy with electrical stimulation on spastic calf muscles in children with cerebral palsy.
Kang BS; Bang MS; Jung SH
Am J Phys Med Rehabil; 2007 Nov; 86(11):901-6. PubMed ID: 17873826
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy.
Kay RM; Rethlefsen SA; Fern-Buneo A; Wren TA; Skaggs DL
J Bone Joint Surg Am; 2004 Nov; 86(11):2377-84. PubMed ID: 15523006
[TBL] [Abstract][Full Text] [Related]
15. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
16. Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.
Linder M; Schindler G; Michaelis U; Stein S; Kirschner J; Mall V; Berweck S; Korinthenberg R; Heinen F
Eur J Neurol; 2001 Nov; 8 Suppl 5():120-6. PubMed ID: 11851740
[TBL] [Abstract][Full Text] [Related]
17. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.
Ubhi T; Bhakta BB; Ives HL; Allgar V; Roussounis SH
Arch Dis Child; 2000 Dec; 83(6):481-7. PubMed ID: 11087280
[TBL] [Abstract][Full Text] [Related]
18. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
19. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy?
Bar-On L; Van Campenhout A; Desloovere K; Aertbeliën E; Huenaerts C; Vandendoorent B; Nieuwenhuys A; Molenaers G
Arch Phys Med Rehabil; 2014 Mar; 95(3):515-23. PubMed ID: 23994052
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin injections minimally affect modelled muscle forces during gait in children with cerebral palsy.
Wesseling M; Kainz H; Hoekstra T; Van Rossom S; Desloovere K; De Groote F; Jonkers I
Gait Posture; 2020 Oct; 82():54-60. PubMed ID: 32892101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
